University of Cincinnati

Running trials

• Not yet recruiting

  Self-administered Acupressure in Patients With Sickle Cell Disease

  NCT07875777· Source

• Not yet recruiting

  COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

  NCT07281027· PHASE3· Source

• Recruiting

  Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

  NCT07665372· Source

• Recruiting

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· PHASE3· Source

• Recruiting

  Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)

  NCT07528638· Source

• Not yet recruiting

  Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency

  NCT07385846· PHASE1· Source

• Recruiting

  Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

  NCT07318597· PHASE2· Source

• Recruiting

  An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

  NCT07365332· PHASE3· Source

• Recruiting

  Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies

  NCT07447895· Source

• Recruiting

  Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

  NCT07676565· Source

• Recruiting

  Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

  NCT07477639· PHASE1 PHASE2· Source

• Enrolling by invitation

  Healthy Eating for My Infant: A Community- Informed Infant Obesity Prevention Program Addressing the Impact of Maternal Mental Health on Eating and Feeding

  NCT07284108· Source

• Recruiting

  A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

  NCT07154823· Source

• Recruiting

  A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  NCT07188558· PHASE3· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

  NCT07227454· PHASE3· Source

• Recruiting

  A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

  NCT07225946· PHASE3· Source

• Recruiting

  Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL

  NCT07014917· PHASE2· Source

• Recruiting

  A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  NCT07276399· PHASE3· Source

• Recruiting

  Zymfentra (Infliximab-dyyb) REal World Cohort STudy

  NCT07237516· Source

• Recruiting

  A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

  NCT07221500· PHASE2· Source

• Recruiting

  A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

  NCT07164443· PHASE3· Source

• Recruiting

  Telerehabilitation In The Home After Stroke

  NCT06682429· Source

• Recruiting

  Study of Epcoritamab as a Consolidation Therapy in CLL/SLL

  NCT07108998· PHASE2· Source

• Recruiting

  Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  NCT06699849· PHASE2· Source

• Recruiting

  Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

  NCT06750731· Source

• Recruiting

  An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

  NCT06951217· PHASE2· Source

• Active, not recruiting

  A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)

  NCT06941844· PHASE3· Source

• Recruiting

  A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

  NCT06708897· PHASE1· Source

• Active, not recruiting

  Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

  NCT06869785· PHASE3· Source

• Recruiting

  A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

  NCT06765668· PHASE4· Source

• Recruiting

  Genetic and Environmental Risk Factors for Hemorrhagic Stroke

  NCT00682695· Source

• Active, not recruiting

  Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

  NCT06578247· PHASE3· Source

• Recruiting

  A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

  NCT06343805· PHASE1· Source

• Recruiting

  Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

  NCT06510374· PHASE3· Source

• Recruiting

  A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

  NCT06545955· PHASE3· Source

• Recruiting

  Image Detection of Impaired Microcirculatory Reperfusion

  NCT07099599· Source

• Active, not recruiting

  A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

  NCT06238622· PHASE3· Source

• Recruiting

  A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

  NCT06163534· Source

• Enrolling by invitation

  Long-term Safety and Tolerability of BHV-7000

  NCT06443463· PHASE2· Source

• Recruiting

  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  NCT06463587· PHASE3· Source

• Active, not recruiting

  A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

  NCT06095128· PHASE4· Source

• Recruiting

  Effect of C-peptide on Hypoglycemic Counterregulation

  NCT06470295· EARLY PHASE1· Source

• Recruiting

  Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

  NCT06366789· PHASE1· Source

• Active, not recruiting

  A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

  NCT06045754· PHASE4· Source

• Active, not recruiting

  P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

  NCT06014762· PHASE1· Source

• Active, not recruiting

  A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

  NCT06329401· PHASE2· Source

• Active, not recruiting

  A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

  NCT06132893· PHASE2 PHASE3· Source

• Recruiting

  The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

  NCT06324201· Source

• Recruiting

  HIT-Stroke Trial 2

  NCT06268041· Source

• Active, not recruiting

  A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease

  NCT06150820· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke7 recruiting
• Chronic lymphocytic leukaemia6 recruiting
• Acute myeloid leukemia4 recruiting
• Atrial fibrillation3 recruiting
• Diffuse large B-cell lymphoma3 recruiting
• Head and neck cancer3 recruiting
• Multiple myeloma3 recruiting
• Acute lymphoblastic leukaemia2 recruiting
• Bladder cancer2 recruiting
• Cervical cancer2 recruiting
• Childhood cancers2 recruiting
• Crohn's disease2 recruiting
• Epilepsy2 recruiting
• Follicular lymphoma2 recruiting
• High blood pressure2 recruiting
• Lung cancer2 recruiting
• Melanoma2 recruiting
• Myelodysplastic syndromes2 recruiting
• Myeloproliferative neoplasms2 recruiting
• Prostate cancer2 recruiting
• Pulmonary arterial hypertension2 recruiting
• Sickle cell disease2 recruiting
• Type 1 diabetes2 recruiting
• Ulcerative colitis2 recruiting
• Alzheimer disease1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Cystic fibrosis1 recruiting
• Depression1 recruiting
• Duchenne muscular dystrophy1 recruiting
• Glioblastoma1 recruiting
• Heart failure1 recruiting
• HIV1 recruiting
• Huntington's disease1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Lupus (SLE)1 recruiting
• Mantle cell lymphoma1 recruiting
• Multiple sclerosis1 recruiting
• Myasthenia gravis1 recruiting
• Obesity1 recruiting
• Parkinson disease1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease

  NCT06881836· PHASE2· Source

• Completed

  A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

  NCT06785012· PHASE2· Source

• Recruiting

  A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT06667076· PHASE2· Source

• Completed

  Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

  NCT06247735· PHASE2· Source

• Completed

  Phase 1 Study to Assess Safety and Efficacy of ANG003

  NCT06052293· PHASE1· Source

• Completed

  Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence

  NCT05783297· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· PHASE3· Source

• Completed

  A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

  NCT05651711· PHASE3· Source

• Completed

  Study of DF9001 in Patients With Advanced Solid Tumors

  NCT05597839· PHASE1 PHASE2· Source

• Completed

  A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

  NCT05560646· PHASE2· Source

• Completed

  Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke

  NCT05585606· PHASE2· Source

• Completed

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· PHASE3· Source

• Completed

  Developing an EEG Probe for Studying and Modulating Cognitive Control

  NCT05612659· Source

• Completed

  Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder

  NCT05536414· PHASE2· Source

• Completed

  DiSCERN: Advanced PD Therapy Candidacy and Evaluation System

  NCT05351580· Source

• Completed

  Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue

  NCT04972097· Source

• Completed

  A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

  NCT05014672· PHASE2· Source

• Completed

  Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

  NCT05130970· PHASE2· Source

• Completed

  Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)

  NCT04846868· PHASE3· Source

• Completed

  A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH)

  NCT04813926· Source

• Recruiting

  A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

  NCT04951622· PHASE3· Source

• Completed

  A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients

  NCT04075916· PHASE2· Source

• Completed

  Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

  NCT04708782· PHASE3· Source

• Completed

  HRV as a Marker of Treatment Response in PAH Arterial Hypertension

  NCT04451850· Source

• Completed

  ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study

  NCT04431258· PHASE1 PHASE2· Source

• Completed

  DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)

  NCT04825834· Source

• Completed

  DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma

  NCT04334759· PHASE3· Source

• Completed

  A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid Tumors

  NCT04670679· PHASE1· Source

• Completed

  A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

  NCT04521478· PHASE2· Source

• Completed

  REal-World Analyses of Stroke - Thrombus Occlusion REtrieval

  NCT04451525· Source

• Completed

  Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML

  NCT04139434· PHASE1· Source

• Completed

  Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

  NCT04023552· PHASE3· Source

• Completed

  Trial of Parkinson's And Zoledronic Acid

  NCT03924414· PHASE4· Source

• Recruiting

  A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

  NCT04065399· PHASE1 PHASE2· Source

• Completed

  Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

  NCT03904693· PHASE3· Source

• Completed

  CCR5-modified CD4+ T Cells for HIV Infection

  NCT03666871· PHASE1 PHASE2· Source

• Recruiting

  Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

  NCT03817502· PHASE3· Source

• Completed

  HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients

  NCT03734393· Source

• Completed

  PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer

  NCT03455608· Source

• Completed

  Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial

  NCT03500328· Source

• Completed

  HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients

  NCT03500315· Source

• Completed

  Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care

  NCT03460483· Source

• Completed

  Recovery and Outcomes From Stroke

  NCT04007757· Source

• Completed

  A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

  NCT02815891· Source

• Completed

  Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

  NCT02486718· PHASE3· Source

• Recruiting

  JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

  NCT02468024· PHASE3· Source

• Completed

  Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors

  NCT01824875· PHASE2· Source

• Completed

  Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

  NCT01546987· PHASE3· Source

• Completed

  S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

  NCT01120249· PHASE3· Source

• Completed

  Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy

  NCT00980954· PHASE3· Source

Trial sites

• University of Cincinnati165 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Stroke347 works · 15 trials
• Obesity217 works · 2 trials
• Asthma197 works · 0 trials
• HIV135 works · 6 trials
• Parkinson disease105 works · 7 trials
• Epilepsy103 works · 4 trials
• Type 1 diabetes99 works · 3 trials
• Sickle cell disease95 works · 3 trials
• Cystic fibrosis90 works · 4 trials
• Acute myeloid leukemia85 works · 7 trials
• Childhood cancers82 works · 3 trials
• Bipolar disorder80 works · 0 trials
• Pancreatic cancer78 works · 3 trials
• Crohn's disease66 works · 3 trials
• Pulmonary arterial hypertension61 works · 6 trials
• Autism55 works · 0 trials
• Head and neck cancer54 works · 10 trials
• Migraine52 works · 0 trials
• Acute lymphoblastic leukaemia50 works · 4 trials
• Duchenne muscular dystrophy43 works · 1 trials
• Chronic lymphocytic leukaemia40 works · 8 trials
• Atopic dermatitis (eczema)39 works · 1 trials
• Endometrial cancer38 works · 2 trials
• Myelodysplastic syndromes22 works · 3 trials
• Hypertrophic cardiomyopathy20 works · 0 trials
• Idiopathic pulmonary fibrosis19 works · 7 trials
• Thalassaemia15 works · 0 trials
• Gaucher disease10 works · 0 trials
• Pompe disease10 works · 1 trials
• Fabry disease8 works · 0 trials